Similarly, we have found moDCs of patients with SLE in active phase could produce higher levels of IL-6, CCL2, and CLL5, which might contribute to explain the dynamic role of these cells in disease pathogenesis. Here, CCL2 is linked to systemic lupus erythematosus.